Siblings Patents [0/5] Conference Papers/Meeting Abstract [6/7] Collection Statistics Item counts issued in 3 years:8(17.78%) Items With Fulltext:44(97.78%) Download counts of the item Download times greater than 0:44(100.00%) Download times greater than 100:40(90.91%) Total Bitstream Download Counts:21489(92.73%) Last Update: 2025-04-20 01:47 Top Upload Loading... Top Download Loading... Recent Submissions Crosstalk between FTH1 and PYCR1 dy... Downregulation of PAX1 in OSCC Enha... The mitochondrial stress signaling ... Crosstalk between FTH1 and PYCR1 dy... Tumor promoting effect of PDLIM2 do... Metastasis and immunosuppression pr... Mitochondrial Lon-induced mitophagy... Mitochondrial oxidative stress in t... A Fc-VEGF chimeric fusion enhances ... Lon upregulation contributes to cis...

Jump to a point in the index: (Choose year) 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1985 1980 1975 1970 1960 1950 (Choose month) January February March April May June July August September October November December Or type in a year:

Ordering With Most Recent First Show Oldest First

Showing items 1-10 of 45. (5 Page(s) Totally) 1 2 3 4 5 > >> View [10|25|50] records per page

Date	Title	Relation
2025-03-27	Crosstalk between FTH1 and PYCR1 dysregulates proline metabolism and mediates cell growth in KRAS-mutant pancreatic cancer cells[Erratum:Experimental and Molecular Medicine. 2024 Sep 18;56:2065-2081.]	Experimental and Molecular Medicine. 2025 Mar 27;57(3):700-701.
2025-01-02	Downregulation of PAX1 in OSCC Enhances Stemness and Immunosuppression via IFIT1 and PD-L1 Pathways	Oral Diseases. 2025 Jan 02;Article in Press.
2024-09-20	The mitochondrial stress signaling tunes immunity from a view of systemic tumor microenvironment and ecosystem	iScience. 2024 Sep 20;27(9):Article number 110710.
2024-09-18	Crosstalk between FTH1 and PYCR1 dysregulates proline metabolism and mediates cell growth in KRAS-mutant pancreatic cancer cells	Experimental and Molecular Medicine. 2024 Sep 18;56:2065-2081.
2024-06-17	Tumor promoting effect of PDLIM2 downregulation involves mitochondrial ROS, oncometabolite accumulations and HIF-1alpha activation	Journal of Experimental and Clinical Cancer Research. 2024 Jun 17;43:Article number 169.
2023-10	Metastasis and immunosuppression promoted by mtDNA and PD-L1 in extracellular vesicles are reversed by WGP beta-glucan in oral squamous cell carcinoma	Cancer Science. 2023 Oct;114(10):3857-3872.
2023-03-16	Mitochondrial Lon-induced mitophagy benefits hypoxic resistance via Ca2+-dependent FUNDC1 phosphorylation at the ER-mitochondria interface	Cell Death and Disease. 2023 Mar 16;14(3):Article number 199.
2023-02	A Fc-VEGF chimeric fusion enhances PD-L1 immunotherapy via inducing immune reprogramming and infiltration in the immunosuppressive tumor microenvironment	Cancer Immunology Immunotherapy. 2023 Feb;72(2):351-369.
2022-09-26	Mitochondrial oxidative stress in the tumor microenvironment and cancer immunoescape: foe or friend?	Journal of Biomedical Science. 2022 Sep 26;29:Article number 74.
2022-09	Beta-glucan therapy converts the inhibition of myeloid-derived suppressor cells in oral cancer patients	Oral Diseases. 2022 Sep;28(6):1484-149.

Showing items 1-10 of 45. (5 Page(s) Totally) 1 2 3 4 5 > >> View [10|25|50] records per page